Emendo Biotherapeutics vs Immunai
Emendo Biotherapeutics vs Immunai, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Emendo Biotherapeutics is on 59/100 and Immunai on 69/100.
Where each one leads
Emendo Biotherapeutics
- agent readiness: 40/100 against 32/100
Immunai
- our overall score: 69/100 against 59/100
- domain rating: 46/100 against 20/100
- headcount: 179 against 41
- headcount growth: +13.0% against -16.1%
- funding raised: $295M against $61.0M
- LinkedIn following: 26,832 against 5,333
At a glance
| Measure | Emendo Biotherapeutics | Immunai |
|---|---|---|
| What it is | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. |
| Category | Healthcare, Genome Editing, CRISPR, Biotech | Healthcare, Immunology, Data, Analytics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2015 | 2019 |
| Headquarters | Tel Aviv, Israel | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Emendo Biotherapeutics | Immunai |
|---|---|---|
| Employees | 41 | 179 |
| Headcount growthLast 12 months | -16.1% | +13.0% |
| Total funding | $61.0M | $295M |
| Latest round | Series B | Series B |
| Valuation | Not published | $1.0B |
| LinkedIn followers | 5,333 | 26,832 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Emendo Biotherapeutics | Immunai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 69/100 |
| Traction | 55/100 | 60/100 |
| Team | 40/100 | 70/100 |
| Search visibility | 44/100 | 39/100 |
| Quality | 68/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Emendo Biotherapeutics | Immunai |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Bootstrap | Jquery, Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
Emendo Biotherapeutics vs Immunai: common questions
Which is better, Emendo Biotherapeutics or Immunai?
On our 0-100 score Immunai rates higher (69/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Emendo Biotherapeutics and Immunai compare on the numbers?
Emendo Biotherapeutics leads on agent readiness (40/100 against 32/100). Immunai leads on our overall score (69/100 against 59/100), domain rating (46/100 against 20/100), headcount (179 against 41), headcount growth (+13.0% against -16.1%), funding raised ($295M against $61.0M), LinkedIn following (26,832 against 5,333).
Read the full Emendo Biotherapeutics review and pricing or the Immunai review and pricing. You can also browse other Emendo Biotherapeutics alternatives we track.